gallbladder carcinoma (Cancer)
Information
- Disease name
- gallbladder carcinoma
- Disease ID
- DOID:4948
- Description
- "A gallbladder cancer that has_material_basis_in abnormally proliferating cells derives_from epithelial cells." [url:https\://www.mayoclinic.org/diseases-conditions/gallbladder-cancer/symptoms-causes/syc-20353370]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT02151084 | Active, not recruiting | Phase 2 | A Study of Different Dosing Schedules of Selumetinib With Cisplatin/Gemcitabine (CIS/GEM) Versus CIS/GEM Alone in Biliary Cancer | November 2014 | December 2025 |
| NCT04853017 | Active, not recruiting | Phase 1 | A Study of ELI-002 in Subjects With KRAS Mutated Pancreatic Ductal Adenocarcinoma (PDAC) and Other Solid Tumors | October 4, 2021 | March 2026 |
| NCT02834013 | Active, not recruiting | Phase 2 | Nivolumab and Ipilimumab in Treating Patients With Rare Tumors | January 30, 2017 | May 1, 2026 |
| NCT05222854 | Active, not recruiting | Comprehensive Genomic Profiling Combined With Real Life Data of "The German-Registry of Incidental Gallbladder Carcinoma" | October 11, 2017 | December 2099 | |
| NCT02649712 | Completed | N/A | Unilateral Stenting Versus Bilateral Stenting for Malignant Hilar Biliary Obstruction | January 20, 2016 | October 31, 2018 |
| NCT04740164 | Completed | N/A | A Dual Channel Supraglottic Airway Device (LMA Gastro) for Oxygenation in Patients Undergoing ERCP | February 14, 2021 | May 4, 2023 |
| NCT02333188 | Completed | Phase 1 | Genetic Analysis-Guided Dosing of FOLFIRABRAX in Treating Patients With Advanced Gastrointestinal Cancer | December 2014 | December 2017 |
| NCT03201458 | Completed | Phase 2 | Atezolizumab With or Without Cobimetinib in Treating Patients With Metastatic Bile Duct Cancer That Cannot Be Removed by Surgery or Gallbladder Cancer | February 8, 2018 | February 19, 2024 |
| NCT05009953 | Not yet recruiting | Phase 2 | Study of Irinotecan Liposome Injection in Patients With Advanced Biliary Tract Cancer | September 2021 | August 2024 |
| NCT05681949 | Not yet recruiting | N/A | Therapeutic Assistance and Decision-making Algorithms in Hepatobiliary Tumor Boards | November 2023 | July 2025 |
| NCT05712356 | Recruiting | Phase 2 | A Study of LSTA1 When Added to Standard of Care Versus Standard of Care Alone in Patients With Advanced Solid Tumors | August 24, 2023 | December 2025 |
| NCT04068194 | Recruiting | Phase 1/Phase 2 | Testing the Combination of New Anti-cancer Drug Peposertib With Avelumab and Radiation Therapy for Advanced/Metastatic Solid Tumors and Hepatobiliary Malignancies | April 7, 2020 | December 3, 2024 |
| NCT04183712 | Recruiting | Phase 2 | Target Therapy With GEMOX in Recectable Gallbladder Carcinoma Patients Monitored by ctDNA | June 1, 2020 | December 2023 |
| NCT04430738 | Recruiting | Phase 1/Phase 2 | Tucatinib Plus Trastuzumab and Oxaliplatin-based Chemotherapy or Pembrolizumab-containing Combinations for HER2+ Gastrointestinal Cancers | September 15, 2020 | October 31, 2025 |
| NCT05194072 | Recruiting | Phase 1 | A Study of SGN-B7H4V in Advanced Solid Tumors | January 12, 2022 | January 31, 2027 |
| NCT05285358 | Recruiting | Phase 1 | Pressurized Intraperitoneal Aerosolized Nab-Paclitaxel in Combination With Gemcitabine and Cisplatin for the Treatment of Biliary Tract Cancer Patients With Peritoneal Metastases | September 19, 2022 | October 11, 2028 |
| NCT01855724 | Terminated | Phase 2 | Clinical Trial to Investigate the Efficacy of Treatment With Gemcitabine/Pazopanib in Patients With Biliary Tree Cancer | June 28, 2013 | September 28, 2018 |
| NCT00767234 | Terminated | Permission to Collect Blood Over Time for Research | August 2008 | October 2011 | |
| NCT03702491 | Unknown status | Phase 2 | Apapitatin Combined With SOX for Palliative Adjuvant Chemotherapy in Patients With Advanced Gallbladder Carcinoma | August 10, 2018 | August 10, 2020 |
| NCT03581435 | Unknown status | A Study of Circulating Exosome Proteomics In Gallbladder Carcinoma Patients | January 1, 2018 | December 1, 2019 | |
| NCT02105350 | Withdrawn | Phase 1 | A Study of MEK162 With Gemcitabine and Oxaliplatin in Biliary Cancer | June 2015 | June 2015 |
- Disase is a (Disease Ontology)
- DOID:3121
- Cross Reference ID (Disease Ontology)
- NCI:C3844
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:93810008
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0235782
- Exact Synonym (Disease Ontology)
- cancer of the gallbladder
- Exact Synonym (Disease Ontology)
- carcinoma gallbladder
- Exact Synonym (Disease Ontology)
- carcinoma of gallbladder